Gilead Sciences, Inc. (GILD) gained around 8% in last week and continued rising in trading today, backed by favorable company news and strong performance of its top drug, Sovaldi.
Gilead Sciences, Inc. (GILD) gained around 8% in last week and continued rising in trading today, backed by favorable company news and strong performance of its top drug, Sovaldi.
Share this Article
Comment on this Article
Recommended
Please to comment